199 related articles for article (PubMed ID: 6265487)
1. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
Gill JR; Bartter FC
J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone.
Gomez-Sanchez CE; Gill JR; Ganguly A; Gordon RD
J Clin Endocrinol Metab; 1988 Sep; 67(3):444-8. PubMed ID: 2842358
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.
New MI; Peterson RE; Saenger P; Levine LS
J Clin Endocrinol Metab; 1976 Dec; 43(6):1283-93. PubMed ID: 187612
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid hypertension in childhood.
New MI; Levine LS
Mayo Clin Proc; 1977 May; 52(5):323-8. PubMed ID: 323586
[TBL] [Abstract][Full Text] [Related]
5. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Stockigt JR; Scoggins BA
J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
[TBL] [Abstract][Full Text] [Related]
6. Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Sep; 85(9):3313-8. PubMed ID: 10999827
[TBL] [Abstract][Full Text] [Related]
7. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
[TBL] [Abstract][Full Text] [Related]
8. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
Oberfield SE; Levine LS; Stoner E; Chow D; Rauh W; Greig F; Lee SM; Lightner E; Witte M; New MI
J Clin Endocrinol Metab; 1981 Jul; 53(1):158-64. PubMed ID: 7016891
[TBL] [Abstract][Full Text] [Related]
9. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
[TBL] [Abstract][Full Text] [Related]
10. Effect of naloxone on the adrenal cortex in primary aldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206
[TBL] [Abstract][Full Text] [Related]
11. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
Pang S; Levine LS; Stoner E; Opitz JM; Pollack MS; Dupont B; New MI
J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166
[TBL] [Abstract][Full Text] [Related]
12. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
Grim CE; Weinberger MH
Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
[TBL] [Abstract][Full Text] [Related]
13. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
Stowasser M; Gordon RD; Klemm SA; Tunny TJ
J Clin Endocrinol Metab; 1993 Sep; 77(3):800-4. PubMed ID: 8396580
[TBL] [Abstract][Full Text] [Related]
14. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic adrenocorticotropin stimulation on the excretion of 18-hydroxycortisol and 18-oxocortisol.
Gomez-Sanchez CE; Clore JN; Estep HL; Watlington CO
J Clin Endocrinol Metab; 1988 Aug; 67(2):322-6. PubMed ID: 2839536
[TBL] [Abstract][Full Text] [Related]
16. Mild adrenal 3 beta-hydroxysteroid dehydrogenase deficiency with hyperaldosteronism.
Hashimoto K; Makino S; Takao T; Sugawara M; Suemaru S; Ota Z
Endocrinol Jpn; 1988 Oct; 35(5):675-83. PubMed ID: 3220046
[TBL] [Abstract][Full Text] [Related]
17. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
[TBL] [Abstract][Full Text] [Related]
18. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
[TBL] [Abstract][Full Text] [Related]
19. Primary aldosteronism due to unilateral adrenal hyperplasia.
Ganguly A; Zager PG; Luetscher JA
J Clin Endocrinol Metab; 1980 Nov; 51(5):1190-4. PubMed ID: 6252233
[TBL] [Abstract][Full Text] [Related]
20. Primary hyperaldosteronism in childhood due to unilateral macronodular hyperplasia. Case report.
Oberfield SE; Levine LS; Firpo A; Lawrence D; Stoner E; Levy DJ; Sen S; New MI
Hypertension; 1984; 6(1):75-84. PubMed ID: 6319281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
